Cabozantinib

Cabozantinib is a strategist that cuts off the cancer's "escape routes." Standard drugs often fail over time because the tumor finds bypass pathways to grow (via MET and AXL proteins). Cabozantinib is unique: it blocks not just the tumor's blood supply (starving it), but also these backup survival mechanisms simultaneously. This makes it the go-to weapon for advanced kidney and liver cancers, especially when the tumor has outsmarted other treatments.